• About
    • Login
    View Item 
    •   Institutional Repository Home
    • Electronic Theses and Dissertations
    • Electronic Theses and Dissertations
    • View Item
    •   Institutional Repository Home
    • Electronic Theses and Dissertations
    • Electronic Theses and Dissertations
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of Institutional RepositoryCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsDepartmentThis CollectionBy Issue DateAuthorsTitlesSubjectsDepartment

    My Account

    LoginRegister

    Potentiating M1 and mGlu1 receptors to modulate prefrontal cortical dysfunction in psychiatric diseases

    Maksymetz, James Thomas Michael
    0000-0002-0486-1153
    : http://hdl.handle.net/1803/16013
    : 2020-03-13

    Abstract

    In psychiatric disorders including posttraumatic stress disorder (PTSD) and schizophrenia, dysfunction of the prefrontal cortex (PFC) is associated with cognitive and emotional deficits that involve aberrant afferent integration and intracortical processing. Current treatments for these disorders have limited efficacy, especially concerning PFC-dependent cognitive functions; therefore, there is a critical need to identify novel pharmacological mechanisms to restore PFC function in these disorders. We aimed to identify novel approaches that could be useful to reduce cortical hyperactivity, focusing on macrocircuit-level regulation of afferent drive and microcircuit-level modulation of inhibitory neurotransmission. Stress-induced loss of fear extinction is thought to play a critical role in sustaining pathological fear in PTSD and the PFC is essential for fear extinction by integrating information from the ventral hippocampus (vHipp) and the basolateral amygdala (BLA). We identified that M1 muscarinic acetylcholine receptor activation induces an input-specific long-term depression of synaptic transmission at the vHipp- and BLA-inputs to the PFC and further demonstrated that an M1 positive allosteric modulator (PAM) enhances fear extinction in a preclinical model of PTSD. Intracortical processing involving inhibitory GABAergic interneurons is critical for proper PFC function and a consistent pathophysiological finding in schizophrenia is evidence of inhibitory interneuron dysfunction. We identified mGlu1 as a novel pharmacological target enriched in PFC GABAergic interneurons, and that activation of mGlu1 preferentially increases the activity of somatostatin (SST) interneurons to shift the PFC excitation-inhibition balance towards inhibition. We further demonstrated that an mGlu1 PAM reverses physiological and behavioral deficits in a preclinical model of schizophrenia, suggesting that targeted enhancement of mGlu1 function may rescue inhibitory deficits and lead to novel therapeutics for cognitive dysfunction in schizophrenia. Altogether, these data identify pharmacological mechanisms to reduce cortical hyperactivity and validate M1 and mGlu1 PAMs as novel treatments for PTSD and schizophrenia, respectively.
    Show full item record

    Files in this item

    Icon
    Name:
    MAKSYMETZ-DISSERTATION-2020.pdf
    Size:
    6.481Mb
    Format:
    PDF
    View/Open

    This item appears in the following collection(s):

    • Electronic Theses and Dissertations

    Connect with Vanderbilt Libraries

    Your Vanderbilt

    • Alumni
    • Current Students
    • Faculty & Staff
    • International Students
    • Media
    • Parents & Family
    • Prospective Students
    • Researchers
    • Sports Fans
    • Visitors & Neighbors

    Support the Jean and Alexander Heard Libraries

    Support the Library...Give Now

    Gifts to the Libraries support the learning and research needs of the entire Vanderbilt community. Learn more about giving to the Libraries.

    Become a Friend of the Libraries

    Quick Links

    • Hours
    • About
    • Employment
    • Staff Directory
    • Accessibility Services
    • Contact
    • Vanderbilt Home
    • Privacy Policy